The B cell receptor for antigen (BCR) is a complex of membrane immunoglobulin (mIg) and at least two other proteins, Igor (mb-1) and Ig~ (B29). This complex promotes surface expression of the BCR and acts to transduce an activation signal. We have used a system of/~ heavy chain constructs transfected into murine B cell lines to probe structure-function relationships in the BCR complex. One mutant # chain, in which two polar transmembrane residues (TyrssT, Sersss) are replaced with valine, fails to associate with Igc~ and Ig~/and is incapable of transducing signals as a result of mlg cross-linking. This mutant is expressed on the surface at high levels when transfected into a plasmacytoma line that lacks Igcr whereas wild-type # is retained in this cell line in the endoplasmic reticulum. Pulse-chase and immunoprecipitation analyses indicate that the mutant is more rapidly released from calnexin than the wild-type #. Further, transfection of Iga into this Igor-negative cell line allows release of the/~ chain from calnexin and surface expression of the BCR. These results identify the transmembrane residues of/~ heavy chain that control binding to calnexin and Igor, and suggest that calnexin-dependent intracellular retention is an important control mechanism for expression of the BCR complex.
T
he B cell receptor for antigen (BCR) 1 is a membranebound immunoglobulin (mIg), expressed on the surface of mature B cells as part of a complex of molecules. This complex, which has many features in common with the TCR-CD3 complex (1) , includes Iga (the product of the mb-1 gene) and Igfl ~the product of the B29 gene). Both mb-1 and B29 have been cloned from T cell-subtracted B cell libraries (2) (3) (4) . Igor is a 32-kD phosphoprotein (5-7), and IgB exists as two differentially processed proteins, one 39 kD and one 37 kD, that form disulfide-linked dimers with Igor (8, 9) . Both Igor and IgB have structural homologies to CD3 chains (10) . Igor and Ig~8 are noncovalently associated with mIg, at least in part via polar interactions in the transmembrane (TM) region of the mIg molecule (11, 12) . The two functions of the BCR are internalization of bound antigen for subsequent presentation, and antigen-induced cellular activation. We and others have shown that transmission of the TM activation signal is dependent on an intact BCR complex (11, 12) , whereas the importance of Igc~ and Igfl for the antigen internalization and presentation function of the BCR is less clear (11, 13, 14) .
The fully assembled BCR complex is expressed on mature, antigen responsive B cells but not on B cell progenitors or differentiated plasma cells, which are not antigen responsive. This developmentally regulated expression of the BCR is controlled by two main mechanisms. One is preferential transcription, first of the membrane-bound forms of heavy chains in mature B cells and later of the secreted forms in activated B cells and plasma cells. The other control mechanism is dependent on Igor, which is expressed only in pre-B and mature, surface Ig + B cells. This control of BCR surface expression was the first characterized function of Igor, and again has analogies to surface expression of the TCR complex in T cells (1) . Thus, mlg transfected into either nonlymphoid or plasmacytoma cells, in which Igor is not synthesized, is retained intracellularly and is not expressed efficiently on the plasma membrane (15) (16) (17) . The site of intracellular retention is the endoplasmic reticulum (ER) (16) (17) (18) , but the specific mechanism for mlg retention in the absence of Igol and how Igol promotes surface expression of mlg are not known. Expression of the BCR complex is a model for studying the biochemical mechanisms that control the expression of multimeric membrane receptors.
We have created a number of human/z constructs with nonconservative mutations in the TM and cytoplasmic domains (13), which we have used to define the structural requirements for the formation and function of the BCR complex (11) . One such mutant, called YS:W, in which two polar transmembrane residues, Tyrs87 and Sersss, are replaced with valines, fails to associate with Igo~ and IgB and fails to signal upon antigen binding or to efl~dently present bound antigen. Despite this lack of association with the BCR complex, however, the TM mutant/~ is expressed at levels comparable to wild-type (WT) # or the endogenously produced Ig when transfected into a mouse mature B cell line A20 (13) . Furthermore, unlike a mutation which deletes the cytoplasmic tail of mlg, thereby rendering the molecule phosphatidylinositol linked, the transmembrane mutant YS:W is expressed as an integral membrane protein (19) . Thus, the YS:VV mutant seems to escape the normal control mechanism for the expression ofmlg on the B cell surface, in that it is expressed in the absence of the other molecules of the BCR complex.
We have used these mlg constructs to analyze the mechanisms that control mlg expression, by transfecting the mlg into a cell line that lacks Igor. Our results indicate that binding to the ER chaperone, calnexin, is an important mechanism for retaining # heavy chains intracellularly, and one function of Igo~ may be to release heavy chains from calnexin. Such regulated release from intracellular retention may be a general mechanism for controlling surface expression of multimeric receptor complexes.
Materials and Methods
Ig Constructs and Cell Lines. The Ig constructs used in these studies have been described elsewhere (13) . The WT # consists of a rearranged V-D-J from the mouse plasmacytoma $107 and human C# regions. The two mutants are Tyrss7/Sersss to Val/Val (YS:VV) and Tyrss7 to Phe (Y:F). The functions of these mutants transfected into the mature B lymphoma line A20 have been described previously (13) . Transfectants ofJ558L, a murine plasmacytoma cell line, were prepared similarly by coelectroporating the WT or mutant # constructs with the $107 g chain in a plasmid containing the neomycin resistance gene. After transfection and sdection in G418, the cells were grown in bulk populations (representing a large number of separate transfection events), and were also cloned by limiting dilution. No sorting to isolate higher surface expression was employed. To produce the WT/Igcx transfectant of J558L, J558L WT cells were then further transfected with a vector containing the rob-1 gene (20, kindly provided by Dr. Michel Nussenzwieg, The Rockefeller Universityj New York), which codes for Igc~, as well as the His resistance gene. Histidinol and G418 resistant clones were obtained by limiting dilution. Again, no sorting to isolate higher surface expression was employed.
Antibodies. Affinity-purified goat anti-human # and goat antihuman K (Southern Biotechnology Associates, Birmingham, AL) and normal goat IgG (Cappel Laboratories, Durham, NC) were coupled to CNBr-activated Sepharose CL4B (Sigma Chemical Co., St. Louis, MO) for use in preclearing or immunoprecipitation. Antimouse calnexin antiserum is described elsewhere (21) . Anti-Igc~ antiserum was the kind gift of Dr. John Cambier (National Jewish Medical Center, Denver, CO).
Western Blotting. 25 x 106 cell equivalents of each cell line were lysed with 1% dodecyl maltoside (DM; Anatrace; Maumee, OH) or 1% NP-40 (Sigma Chemical Co.) in lysis buffer (150 mM NaC1, 10 mM Tris, pH 7.3, and 1 mM EDTA) in the presence of protease inhibitors (PMSF, leupeptin, and aprotinin; Sigma Chemical Co.), followed by a 20-min spin at 12,000 g to remove nuclei and membrane fragments. The lysates were precleared with goat IgG-Sepharose, immunoprecipitated with Sepharose-coupled goat anti-human/~, washed, separated by SDS-PAGE, and blotted onto PVDF membranes. The blots were then probed with either alkaline phosphatase anti-human/~ or anti-Igc~ or anticalnexin antisera in the presence of 3 % BSA. Alkaline phosphatase-conjugated goat anti-rabbit IgG (Southern Biotechnology Associates) was used as a secondary antibody where necessary and blots were developed by an alkaline phosphatase reagent system (Vector Labs, Inc., Burlingame, CA). To examine the association of Igcr with transfected /x, the anti-IgM immunoprecipitated proteins were divided into two aliquots and electrophoresed separately. One aliquot was probed for/x heavy chain and the other for Igor.
Pulse-Clutse Analysis. 50-100 x 106 cells were initially incubated in methionine and cysteine-free medium with 5% dialyzed FCS (pulse medium) for 30 min, pelleted, and resuspended in fresh warmed pulse medium with 1 mCi 3sS-Express label (NEN, Boston, MA) for 5-15 min at 37~ An aliquot of 10-20 x 106 cells for time 0 was collected, and the remaining cells were washed and resuspended in complete medium supplemented with methionine for the chase times indicated. At each time point, 10-20 x 106 cells were washed, lysed, precleared, immunoprecipitated with anti-# antibody as above, and analyzed by 8% SDS-PAGE. Gels were run until the 21-kD marker had reached the bottom to optimize separation at 50-100 kD. To determine the proportion of labeled/~ that was bound to calnexin after chase, lysates from each time point were sequentially immunoprecipitated with anticalnexin antiserum followed by anti-mouse K. This allowed separation of # heavy chain that was bound to calnexin from heavy chain that had been released from calnexin, processed, and complexed with light chain. The amount of heavy chain in each immunoprecipitate was quantified by Phosphorlmager (Molecular Dynamics, Inc., Sunnyvale, CA) analysis of 10% SDS-PAGE gels, and the amount of transfected ~ heavy chain bound to calnexin was expressed as a percentage of the total heavy chain immunoprecipitated (bound plus released). For endoglycosidase H (Endo-H) analysis, cells were pulsed with [3SS]methionine for 15 rain and chased in supplemented complete medium as above. Cell aliquots were lysed at each time point and immunoprecipitated with anti-/~ antibody. The proteins coupled to beads were solubilized, divided into two aliquots, and treated with Endo-H or left untreated. The treated and untreated aliquots were then analyzed by 8% SDS-PAGE.
Analysis oflntracelhlar Ca 2+ Flux. 2 x 106 cells were loaded
for 30 min at 37~ with 5/~g/ml Fura-2 (Sigma Chemical Co.). They were then washed and resuspended in balanced salt solution containing 1.8 mM CaC12, placed in cuvettes, and allowed to equilibrate in a fluorimeter (model LS 5B; Perkin Elmer-Cetus Corp., Norwalk, CT) at 370C until baselines were established. Excitation occurred at 339 nm and emission was measured at 510 nm. Antibody or antigen was added and the fluorimetric response was measured. Triton X-100 (Sigma Chemical Co.) was added to 1% to establish a maximum signal, followed by EGTA to 100 mM to establish a minimum. fected WT, YS:VV and Y:F constructs with K light chains into the mouse plasmacytoma line J558L, which is Igcx negative but expresses Ig/3. Fig. 1 shows the results of flow cytometric analysis of J558L transfectants stained with FITCanti-human/~. The W T transfectant of J558L retained the transfected mlgM intracellularly, expressing little or no mlgM on the cell surface. This result, using other # constructs, has been reported previously and is the basis of the conclusion that Igc~ plays a key role in controlling BCP, expression (22) . In striking contrast to the W T construct, the YS:VV mutant was expressed on the plasma membrane at very high levels. The Y:F mutant, which associates with IgoL in A20 cells in To demonstrate that transfectants that failed to express surface IgM did synthesize the protein, cells were lysed in 1% DM in lysis medium and immunoprecipitated with antihuman IgM coupled to Sepharose beads. The immunoprecipitated proteins were split into two aliquots, separated by SDS-PAGE, and transferred to membranes for immunoblot analysis of/~ heavy chain as well as associated Ig~x (see below). Fig. 2 A shows that both WT, YS:W and Y:F # heavy chains were synthesized in J558L cells at levels comparable to A20 transfectants. Therefore, the failure of J558L cells to express the W T /~ is not due to the lack of synthesis of the transfected Ig. These analyses revealed an interesting difference between the constructs. In the two transfectants in which IgM is expressed on the cell surface, i.e., A20 W T andJ558L YS:VV, the heavy chain was seen as a broad band suggestive of a doublet, whereas in the case of the intracellularly retained J558L W T or J558L Y:F, only a narrow, single band was seen. This suggests differential processing of the mutant and W T # in the J558L transfectants, a difference that corresponds to whether the molecule is expressed on the surface or not. It is formally possible that the J558L YS.'VV transfectants are revertants that express Igcz (22) and that this is responsible for surface expression of the transfected, mutant IgM. To demonstrate that no J558L transfectant expressed Igcx inappropriately, aliquots of immunoprecipitated # and #-associated proteins were probed for Ig~x expression by immunoblot using an anti-Igcz antiserum. As shown in Fig. 2 B, no #-associated Igo~ was detectable in any J558L line. The WT transfectant of the Igcz-expressing line A20 was used as a positive control and showed expression of Igcz. A second approach for assessing the integrity of the BCR complex in J558L cells was based on previous work with A20 transfectants, showing that association with IgoL is required for mlg to transduce ligand-induced signals, such as an increase in intracellular Ca 2+ (11, 12 ). Thus, we tested J558L YS:W for the ability to trigger a calcium flux upon cross-linking with anti-/~ antibody. Fura-2-1abeled A20 WT and J558L YS:VV cells were treated with 50/~g/ml anti-/~ and changes in intracellular calcium were assayed with a spectrofluorimeter. This concentration of antibody induced an increase in intracellular calcium in A20 WT, but no such signal was seen in J558L YS:VV (Fig. 3) . Therefore, both biochemical and functional assays establish that the YS:VV mutant is expressed on the surface of J558L cells in the absence of Igor.
Results
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Intracellular Processing of Transfected /~ in J558L.
To further characterize differences in the intracellular processing of the retained WT and the expressed mutant Ig YS:VV and define the site(s) of retention of the WT/~ in the J558L cells, we used a pulse-chase technique. In these experiments, cells were metabolically labeled for a 15-min pulse, followed by a chase for 0~ rain in methionine-supplemented chase medium. In this way, it is possible to follow the cohort of Ig molecules that is synthesized during the short pulse period, looking for changes in apparent molecular weights indicative of processing and glycosylation. After the chase, cells were lysed and IgM immunoprecipitated, followed by SDS-PAGE under conditions designed to emphasize separation in the 50-100-kD range. As seen in Hg. 4 A, a higher Mr form of YS:VV IgM appeared by 150 min, consistent with processing on the way to the plasma membrane. This processing did not take place in the case of the WT IgM, in which the higher Mr form did not appear. In both cases, there was a core, glycosylated form, the presence of which decreased slowly over time, as well as a smaller form which may represent unglycosylated peptide that decreased much more quickly (within 30-60 min). The pattern of processing of the WT/~ suggests that this protein is retained in the ER.
To further define the possible site of intracellular retention of WT IgM, the pulse-chase strategy was used, foUowed by treatment of the immunoprecipitates with Endo-H. The glycosylation of ER resident proteins is typically Endo-H sensitive, whereas passage through the Golgi stack matures the sugar residues and renders the molecule Endo-H resistant. Fig. 4 B shows Endo-H analysis of WT and mutant Ig molecules in J558L transfectants. Directly after a 15-min pulse, almost all of the YS:VV/~ was Endo-H sensitive, consistent with ER localization. After a chase of 150 min, a large fraction of the YS:VV material became Endo-H resistant, indicating movement out of the ER and through the Golgi. This contrasts with WT, which remained entirely Endo-H sensi- tive even at 150 min. Again, this indicates that the W T molecule has been retained within the ER.
Role of Calnexin in Intracellular Retention of ~ Heavy Chains.
Given the EK retention of the W T IgM, it was important to look for a possible retention or chaperone molecule. One recently described candidate is calnexin (IP90, P88; 23, 24), a 90-kD molecule that is involved in EK retention of monomeric proteins until they reach their mature configuration (25) . There is also evidence that calnexin may be involved in the ER retention of multirneric complexes, mediating retention until all members of the complex have been assembled (21, 23, 26) . With this in mind, we used an antiserum to calnexin to probe for calnexin association with both the W T and mutant (YS:W) #. Since the mutant is released from the EK, we hypothesized that this release was on the basis of failure of the mutant # to bind calnexin. Fig. 5 shows that this was not the case. Immunoblot analysis of calnexin associated with W T and YS:W # heavy chain demonstrated that at least some of the # molecules in each case were associated with calnexin. This was true both under more stringent and relatively less stringent lysis and wash conditions; i.e., in cells that were lysed with 1% NP-40 or the weaker nonionic detergent DM.
It was possible that although both mutant and W T # bound to calnexin initially, the kinetics of release from calnexin of each molecule was different. To test this, we used pulse-chase labeling followed by sequential immunoprecipitation, first with anticalnexin antiserum to isolate # protein associated with calnexin, and then with anti-mouse t~ to separate heavy chain that had been released from calnexin and assembled with the transfected light chain. Fig. 6 shows that essentially all (>90%) of the W T # chain was bound to calnexin at all time points examined. By contrast, the mutant # (YS:VV) was released from calnexin over time, with 78% of the # bound at time 0 and only 33% bound by 3 h. Fig. 6 shows the result from one experiment; in a second experiment, >93% of the W T # was calnexin associated at both 0 and 3 h, whereas 80% of the YS:VV # was calnexin associated at time 0 and 48% by 3 h.
Role of Igat in the Release of /~ Heavy Chains from Cal-
nexin. If the failure of the W T # chain to be released from calnexin is indeed due to the absence of Igor, then coexpressing Igc~ should lead to release of # and surface expression of the BCK. To formally test this, we transfected J558L W T cells with Igor. Fig. 7 A shows flow cytometric analysis of J558L W T and J558L WT/Igot cells demonstrating that in J558L WT/Igc~ double transfectants mlgM was expressed at levels equivalent to J558L YS:VV. To examine the release of# from calnexin, J558L WT/Igot transfectants were pulsed with [3SS]methionine for 5 min, chased for 3 h, and the # heavy chain both bound to and released from calnexin was analyzed by SDS-PAGE. As shown in Fig. 7 B, after 3 h of chase, in the J558L W T cells all the # remained calnexin associated, whereas in the J558L WT/Igc~ double transfectants a significant fraction of the # protein was released. Quantitation of the autoradiogram shown in Fig. 7 B revealed that 100% of the # was calnexin bound in J558L W T cells, whereas 36% of the total # protein was released over the same time in J558L WT/Igot cells. Thus, coexpression of Igor releases the W T # protein from calnexin and permits it to be expressed on the cell surface.
D i s c u x i o n
The expression of Ig in B cell lines provides a model for analyzing the control of surface expression and function of integral membrane protein receptor complexes. We have used W T and mutant Ig molecules to characterize the importance of the TM region in mediating two key aspects of the mole- Figure 6 . Release of# from calnexin over time. (A) Cells were labeled with [3sS]methionine for 5 min followed by a chase for the time indicated. DM lysates were sequentially immunoprecipitated with anticalnexin antiserum and anti-K, separating heavy chain bound to calnexin (B) from released heavy chain (R). IgM heavy chain is indicated (a), as well as a band migrating at the correct Mr to be calnexin. (/3) Total incorporation was measured using the PhosphorImager and the amount of immunoprecipitated heavy chain bound to calnexin was expressed as a percent of the total immunoprecipitated # heavy chain. cule's behavior. Previously, we have shown that the TM region mediates association with other molecules of the BCR complex, and thus the signaling capability of the complex. In this study we show that the TM region also determines the surface expression of mlgM. Specifically, the polar residues in the WT TM sequence that are involved in noncovalent association with Igor and Ig/3 also confer on mlgM the requirement for complex assembly before the molecule can be expressed on the cell surface. In the absence of assembly of the complex, synthesized WT mlgM is retained in the ER. A nonconservative dipeptide substitution in the TM region completely changes the behavior of mlgM. This mutant is expressed at high levels on the cell surface without the requirement of complex assembly. Further, our data suggest that association with and release from calnexin are key determinants of surface expression of IgM. When Igor is provided to complete assembly of the complex, WT IgM is released from calnexin and expressed on the cell surface.
Previous studies from other laboratories have also implicated the TM region of # in intracellular retention (27) , but the constructs used differ significantly from ours in two respects. First, Williams et al. (27) used murine/x constructs, whereas we have used human C/z because its expression can be followed unambiguously, and hybrids between transfected and endogenous Ig heavy chains are not seen (13) . It should be noted that the TM regions of human and mouse/~ differ only in a single nonpolar residue at position 572. Second, Williams et al. (27) concluded that the NH2-terminal polar patch of the TM region (TTAST, beginning at residue 572) is involved in retention, using a construct with many more TM residues altered than those employed in our studies. Our data, however, indicate that the COOH-proximal polar region (YSTTVT, beginning at residue 587) is key, both in controlling association with Igor and Ig/3 and in controlling specific intracellular retention. Our analysis of a nonconservative dipeptide mutation in the TTAST region (TTAST to TTAVV) demonstrates intact signaling and binding to Igoz and Ig/3 (11) . The reasons for the differences in our results and those of Williams et al. (27) are not clear, but may relate to the use of different constructs.
The striking expression of mlgM in the absence of associated Igor inJ558L cells has given us a tool for studying how surface expression of this protein is controlled. Calnexin has been implicated in the EtL retention of immature proteins as they are prepared for secretion or surface expression. Monomeric proteins are bound to calnexin during or soon after synthesis and then released when correctly processed and folded (25) , whereas misfolded or aberrantly glycosylated proteins are not released. More recently, calnexin association has also been demonstrated as a potential control mechanism for multimeric complex assembly, for both MHC class I (28) and the TCR-CD3 complex (26) . In these cases, it is hypothesized that single chains of a multimeric complex are retained in the ER by calnexin until all molecules of the complex are assembled, at which time the complex is released for transport to the Golgi and on to the surface. The studies described here support a similar role for calnexin in the expression of the BCR complex. Thus, we postulate that newly synthesized WT/z heavy chains are bound to calnexin and retained in the ER (Fig. 8 ). In this model, Igor, possibly associated with Ig/3, releases/z from its calnexin-binding site, allowing subsequent processing and surface expression. In the absence of Igtx, as in the J558L transfectants, the WT/z remains calnexin bound. In contrast, the YS:W mutant binds only transiently to calnexin and is spontaneously released without the requirement for Igor, resulting in surface expression. Cotransfection of WT # and Igc~ formally shows that Igor is required for the release of the/z heavy chain from calnexin. Note that the YS:VV mutation does not abolish the association between calnexin and the/~ protein, since the mutant transiently binds to calnexin. Given the wide variety of proteins that calnexin chaperones, it seems impossible that there is any consensus sequence motif for calnexin binding. Rather, it is more likely that binding to calnexin is mediated by carbohydrate moieties. This is consistent with the release of monomers as they achieve mature conformation and glycosylation. The YS:W mutation may alter the glycosylation of the/z chain, thereby reducing the avidity of its association with calnexin and allowing "spontaneous" release from the chaperone. In WT # proteins, calnexin-binding carbohydrate moieties may only be detached from calnexin by the binding of the BCR complex compo- nent Igce (with or without Igl3). The mutation in the BCR retention signal described here changes the mutant BCR from a processing pathway appropriate to a multicomponent receptor complex, mandating retention until the whole of the complex is assembled, to a processing pathway requiring only proper folding, glycosylation and, possibly,/zg association.
These studies with Ig transfectants have broad implications for the assembly and expression of multimeric protein receptor
comple~s. An important function of associated proteins, such as Igcx and Igfl for the BCR, may be to release newly synthesized receptors from intracellular retention sites. Developmentally regulated expression of associated proteins will, therefore, control intracellular retention vs. surface expression of the complexes, allowing expression during maturational stages at which the receptors are required for function.
